S-3304 in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: S-3304 may stop or slow the growth of solid tumors by stopping blood flow to the
tumor.
PURPOSE: Phase I trial to study the effectiveness of S-3304 in treating patients who have
solid tumors.